Enanta Pharmaceuticals
ENTA
ENTA
132 hedge funds and large institutions have $225M invested in Enanta Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 45 increasing their positions, 45 reducing their positions, and 25 closing their positions.
Holders
132
Holders Change
-1
Holders Change %
-0.75%
% of All Funds
2.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
25
Increased
45
Reduced
45
Closed
25
Calls
$9K
Puts
$17K
Net Calls
-$8K
Net Calls Change
-$14K
Top Buyers
1 |
1
Millennium Management
New York
|
$11.4M |
2 |
2
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$7.06M |
3 |
3
Acadian Asset Management
Boston,
Massachusetts
|
$6.13M |
4 |
4
D.E. Shaw & Co
New York
|
$4.03M |
5 |
5
Morgan Stanley
New York
|
$6.31M |